ポスター：新たな治療モダリティの効率的な開発・生産を可能にする質量分析データ解析向けエンタープライズソフトウェアプラットフォーム

3月 18, 2025

Mass spectrometry (MS) has become a key analytical technology throughout the entire biopharmaceutical lifecycle, from in-depth characterization of biotherapeutic candidates during discovery and development, to quality monitoring of drug products during manufacturing. By providing a single, scalable solution for all MS data analysis, processing, and reporting while seamlessly integrating into existing analytical processes, the Genedata Expressionist^® enterprise software platform accelerates and streamlines biotherapeutic development across entire organizations.